2024-11-05 - Analysis Report
## Pfizer Inc. (PFE) Stock Analysis Report

**1. Stock Performance and Comparison:**

Pfizer Inc. (PFE) is a pharmaceutical company developing and manufacturing vaccines and medicines. As of the last data point, PFE has **underperformed** the S&P 500 (VOO) by a significant margin, with a cumulative return of **-13.87%** compared to VOO's **131.78%**. This translates to a **-145.65%** difference, placing it within the bottom **2.59%** percentile of its historical performance against the S&P 500. 

**Alpha and Beta Analysis:**

| Year | CAGR | MDD | Alpha | Beta |
|------|------|-----|-------|------|
| 2015 | 1.4% | 13.9% | 1.0% | 0.9 |
| 2016 | 1.4% | 17.9% | -9.6% | 0.7 |
| 2017 | 9.5% | 7.3% | -9.3% | 0.6 |
| 2018 | 20.6% | 13.3% | 32.0% | 0.8 |
| 2019 | -14.0% | 22.4% | -45.1% | 0.8 |
| 2020 | -1.8% | 29.2% | -21.1% | 0.7 |
| 2021 | 67.8% | 17.4% | 25.9% | -0.0 |
| 2022 | -20.0% | 24.0% | 26.2% | 0.5 |
| 2023 | -69.2% | 42.4% | -104.7% | 0.5 |
| 2024 | -1.6% | 6.2% | -36.8% | 0.2 |

The analysis shows a **high volatility** in PFE's performance, with both significant positive and negative returns. The **beta** fluctuates around 0.7, indicating a moderate level of correlation with the overall market, while **alpha** has been mostly negative, suggesting that PFE has **underperformed** the market over the past years.

**2. Recent Price Movement:**

* **Closing Price:** $28.09 (Last-market: $27.87)
* **5-day Moving Average:** $28.45
* **20-day Moving Average:** $28.99
* **60-day Moving Average:** $28.98

The current price is below both the 5-day and 20-day moving averages, suggesting **short-term weakness**. However, it's very close to the 60-day moving average, indicating potential support at this level.

**3. Technical Indicators:**

* **RSI:** 34.29 - This indicates **oversold conditions**, suggesting potential for a short-term rebound.
* **PPO:** -0.34 - A negative PPO value signifies a **weak trend** and potential for further downward movement.
* **Delta_Previous_Relative_Divergence:** +2.34 - This suggests a **positive short-term price movement**.

The current price of $27.87 is very close to the 5-day moving average, so there is **no significant price change** to report. 
* **Expected Return:** 0.0% -  This suggests that over the next 2 years, the potential for exceeding the S&P 500 returns is **limited** at this point.

**4. Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-10-29 | 1.06 | 0.614 |
| 2024-07-30 | 0.6 | 0.458 |
| 2024-05-01 | 0.82 | 0.516 |
| 2024-01-30 | 0.1 | -0.19 |
| 2023-10-31 | -0.17 | -0.32 |

The most recent earnings report (2024-10-29) showed an **EPS of 1.06**, exceeding the expected EPS of **0.614**. This positive surprise could suggest a more positive outlook for the company's future performance.

**5. Financial Information:**

**1) Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---|---|---|
| 2024-06-30 | $13.28B | 75.16% |
| 2024-03-31 | $14.88B | 77.29% |
| 2023-12-31 | $14.25B | 46.92% |
| 2023-09-30 | $13.23B | 29.95% |
| 2023-06-30 | $13.01B | 75.11% |

PFE has been consistently generating significant revenue with a relatively strong profit margin. However, there is a **fluctuation** in profitability, potentially due to factors like R&D spending or changes in product mix.

**2) Capital and Profitability:**

| Quarter | Equity | ROE |
|---|---|---|
| 2024-06-30 | $87.70B | 0.05% |
| 2024-03-31 | $92.28B | 3.38% |
| 2023-12-31 | $89.01B | -3.78% |
| 2023-09-30 | $96.93B | -2.46% |
| 2023-06-30 | $99.02B | 2.35% |

The ROE (Return on Equity) shows significant **variability**, indicating a potential issue with the company's efficiency in using shareholder capital. This warrants further investigation into the reasons for these fluctuations.

**6. News and Recent Issues:**

To get a clear picture of recent news and issues, we need to access more specific information, including:

* **Earnings news:** Detailed analysis of recent earnings announcements from sources like Shacknews or company press releases.
* **Recent Market Outlook:** Expert opinions and sentiment regarding PFE's future prospects.
* **Analyst Opinions and Performance Highlights:** This would include information on price targets, rating changes, and key performance factors from analyst reports. 

**7. Overall Analysis:**

PFE is currently trading at a **significant discount** compared to the S&P 500, exhibiting a **weak short-term trend** with potential for a rebound based on recent earnings and technical indicators. The company's financial performance is marked by **fluctuating profitability** and a **volatile return on equity**, warranting further investigation. However, recent earnings have shown **positive surprises**, which could indicate a potential shift in the future direction of the stock. 

**It's important to note that this analysis is based on limited data and should not be considered investment advice. Investors should conduct thorough research and consult with financial professionals before making any investment decisions.** 
